The indirect regulation of product safety design through pre-market testing is common with pharmaceuticals and other products containing chemical ingredients. We model this problem as a three stage game in which the firm begins by designing safety, next the government supervises a testing process, and finally the firm markets the product if it is approved. We characterize and compare the Nash and the two leadership equilibria of this game, analyze the comparative statics of these solutions, and consider the effects of regulatory misbehavior. We show that the effects of regulatory misbehavior depend crucially the type of firm-regulator interaction. Copyright 1995 by Kluwer Academic Publishers
Download Info
To our knowledge, this item is not available for
download. To find whether it is available, there are three
options:
1. Check below under "Related research" whether another version of this item is available online.
2. Check on the provider's web page
whether it is in fact available.
3. Perform a search for a similarly titled item that would be
available.
For technical questions regarding this item, or to correct its listing, contact: (Christopher F. Baum).
Related research
Keywords:
Other versions of this item:
Cited by: (explanations, Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.)